FDA approved Merck’s Dulera, a combination inhaler, for asthma patients 12 years and older, the company announced today. Dulera consists of an inhaled corticosteroid and a long-acting beta agonist, ...
Sixty-two Percent of Surveyed Pharmacy Directors Expect to Reimburse Boehringer Ingelheim’s Olodaterol/Tiotropium When It Launches in 2013, According to a New Report from HealthLeaders-InterStudy and ...
HONOLULU--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from two 26-week investigational Phase III clinical studies evaluating the ...
Dulera approved for the treatment of asthma Merck announced that the FDA has approved Dulera (mometasone furoate and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck today announced that the U.S. Food and Drug Administration (FDA) has approved DULERA ® (mometasone furoate and formoterol fumarate dihydrate) ...
Asthma is a chronic inflammatory disease characterized by pulmonary inflammation leading to bronchial contraction. Inflammation can cause recurring "attacks" of wheezing, breathlessness, and coughing, ...
WHITEHOUSE STATION, N.J. The Food and Drug Administration has approved a new drug by Merck for treating asthma in patients ages 12 years and older, Merck said Thursday. The FDA approved Dulera ...
asthma inhaler overweight The FDA has approved updated labeling for Asmanex HFA (mometasone furoate; Merck) and Dulera (mometasone furoate, formoterol fumarate; Merck) to include use in pediatric ...
FDA Approves Merck's DULERA(R) (mometasone furoate and formoterol fumarate dihydrate) Inhalation Aerosol for the Treatment of Asthma in Patients 12 Years of Age and Older WHITEHOUSE STATION, N.J., Jun ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results